Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma Anne E. Dixon, MA, BM BCh, Mario Castro, MD, MPH, Rubin I. Cohen, MD, Lynn B. Gerald, PhD, MPH, Janet T. Holbrook, PhD, Charles G. Irvin, PhD, Shyam Mohapatra, PhD, Stephen P. Peters, MD, Sobharani Rayapudi, MD, Elizabeth A. Sugar, PhD, Robert A. Wise, MD Journal of Allergy and Clinical Immunology Volume 135, Issue 3, Pages 701-709.e5 (March 2015) DOI: 10.1016/j.jaci.2014.06.038 Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 1 Eligibility screening, randomization, and follow-up of study participants. All patients were included in the analysis based on the assigned treatment. Journal of Allergy and Clinical Immunology 2015 135, 701-709.e5DOI: (10.1016/j.jaci.2014.06.038) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig E1 Asthma control during study treatment for participants assigned to mometasone and placebo for participants aged 6 to 11 years measured by using the cACT (A) and for participants aged 12 years or older measured by using the ACT (B). Journal of Allergy and Clinical Immunology 2015 135, 701-709.e5DOI: (10.1016/j.jaci.2014.06.038) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions